-
Opiate antagonistic properties of an octapeptide somatostatin analog.
The somatostatin analog D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-NH-CH(CH2OH)CHOHCH3 (SMS 201-995) displaces [3h[naloxone from its binding sites (IC50, 38 +/- 60 nM), being more than 200 times more potent than somatostatin. As measured by the difference between [3H]dihydromorphine, [3H][D-Ala2,D-Leu5]enkephalin, and (-)-[3H]bremazocine binding, SMS 201-995 appears to be highly specific for the opiate mu binding site. Electrophysiological data from hippocampal cultures and results from animal studies (tail flick, mydriasis) demonstrate the opiate antagonistic properties of SMS 201-995. SMS 201-995 is an opiate mu antagonist with a peptide structure. That this property is displayed by a somatostatin analog is somewhat unexpected.
PMID: 6126877 [PubMed - indexed for MEDLINE]
PMCID: PMC346769
-
Cited by 4 PubMed Central articles
-
Molecular dynamics study of peptide-bilayer adsorption.
Shepherd CM, Schaus KA, Vogel HJ, Juffer AH.
Biophys J. 2001 Feb; 80(2):579-96.
[Biophys J. 2001]
-
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, Bell GI.
Proc Natl Acad Sci U S A. 1993 Jul 15; 90(14):6736-40.
[Proc Natl Acad Sci U S A. 1993]
-
Molecular characterization of the solubilized receptor of somatostatin from rat pancreatic acinar membranes.
Knuhtsen S, Esteve JP, Bernadet B, Vaysse N, Susini C.
Biochem J. 1988 Sep 15; 254(3):641-7.
[Biochem J. 1988]
- » See all...